Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
BMJ Case Reports|March 28, 2025
Diagnostic challenges in DAT-negative autoimmune haemolytic anaemiaLaura McDuff, Marcus Lombard, Tony Calogero, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 24, 2008
Catastrophic bleeds during end-of-life care in haematology: controversies from Australian researchPam McGrath, Michael Leahy
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 11, 2005
Cost and utilization impacts of oral antihistamines in the California Medi-Cal programJoel W Hay, Michael Leahy
Health Affairs (Project Hope)|April 3, 2018
Affordable Care Act's Cadillac Tax Could Affect One-Fourth Of Workers With Employer Health Coverage By 2025Mark J Warshawsky, Michael Leahy
The Australian & New Zealand Journal of Obstetrics & Gynaecology|March 26, 2026
The Effect of COVID-19 During Pregnancy on Obstetric and Neonatal Outcomes: A Retrospective Case-Control StudyLaura McDuff, Patricia de Gouveia Belinelo, Simon Lawrance, et al.
The Patient|January 26, 2012
And Tell Yourself, "This is not Me, it's the Drug": Coping with the Psychological Impact of Corticosteroid Treatments in Hematology - Further Results from a Pilot StudyPam McGrath, Mary Anne Patton, Michael Leahy
Transfusion Medicine (Oxford, England)|September 20, 2023
Does decreasing the incubation period used in the antibody screen affect its sensitivity?Grace Kenneday, Hui Jun Chih, Susan Finch, et al.
The Australasian Journal of Dermatology|February 8, 2012
Treatment-resistant elephantiasic thyroid dermopathy responding to rituximab and plasmapheresisChristopher Heyes, Richard Nolan, Michael Leahy, et al.
Pathology|November 23, 2012
Differential expression of the Bcl-2 and Bax isoforms in CD19 positive B-lymphocytes isolated from patients diagnosed with chronic lymphocytic leukaemiaReza Ghassemifar, Luke Forster, Jill Finlayson, et al.
Sarcoma|October 17, 2006
A Phase II Nonrandomised Open-Label Study of Liposomal Daunorubicin (DaunoXome) in Advanced Soft Tissue SarcomaAnne McTiernan, Jeremy Whelan, Michael Leahy, et al.
Pageof 5